Skip to main content

Year: 2020

Glatfelter Reports Third Quarter 2020 Results

CHARLOTTE, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) — Glatfelter Corporation (NYSE: GLT), a leading global supplier of engineered materials, today reported its results for the third quarter of 2020 which are summarized in the following table:On an adjusted basis, earnings from continuing operations for the three months ended September 30, 2020 and 2019, were $7.0 million, or $0.16 per share, compared with $9.7 million, or $0.22 per share, respectively. Adjusted earnings is a non-GAAP financial measure for which a reconciliation to the nearest GAAP-based measure is provided within this release. Consolidated net sales for the three months ended September 30, 2020 totaled $233.5 million compared with $232.5 million during the same period in 2019. On a constant currency basis, Composite Fibers’ and Airlaid Materials’ net sales decreased...

Continue reading

Bonanza Creek Announces Transformative Agreement to Acquire Restructured HighPoint Resources

Creates a company of scale in the rural DJ Basin with production of 50,000 Boe/d and a consolidated, contiguous leasehold position of approximately 206,000 net acresAccretive on all key financial metrics with a transformative impact on sustainable free cash flow generationDENVER, Nov. 09, 2020 (GLOBE NEWSWIRE) — Bonanza Creek Energy, Inc. (“Bonanza Creek” or the “Company”) (NYSE: BCEI) and HighPoint Resources Corporation (“HighPoint”) (NYSE: HPR) today announced that they have entered into a definitive merger agreement to combine Bonanza Creek and HighPoint in a transaction valued at approximately $3761 million as of November 6, 2020. The transaction value is based on the equity to be issued to HighPoint equity holders, the equity and debt to be issued to HighPoint debt holders in connection with the Exchange Offer (as defined below)...

Continue reading

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob Chacko, M.D., chief executive officer, will participate in the following investor conferences in November:Jefferies Virtual London Healthcare Conference – Participating in a virtual fireside chat on November 18, 2020 at 5:00 p.m. GMT/9:00 a.m. PT; andSVB Leerink Oncology 1×1 Day – Hosting virtual investor meetings on November 19, 2020A live webcast of the fireside chat will be available through the investor section of the company’s website at  www.oricpharma.com. A replay of the webcast will be available for 90 days following the events.About ORIC Pharmaceuticals,...

Continue reading

LogicBio Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update

– IND for LB-001 in methylmalonic acidemia (MMA) cleared in August 2020, with first patient in Phase 1/2 SUNRISE trial expected to be enrolled in early 2021– Fast Track designation for LB-001 in MMA received in November 2020– First follow-on offering post-IPO closed in October 2020LEXINGTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, today reported financial results for the quarter ended September 30, 2020 and provided a business update.“LogicBio has recently marked several important achievements, which could set the stage for exciting news from our company in the quarters to come,” said Frederic Chereau, President and CEO. “Over the last several...

Continue reading

Information Services Group Announces Third-Quarter 2020 Results

Reports third-quarter revenues of $61.6 million; adjusted EBITDA of $8.2 million, both exceeding guidanceReports net income of $2.1 million, up 19%; GAAP EPS of $0.04, flat; adjusted EPS of $0.10, up 11% (vs. PY)Delivers quarterly cash flow from operating activities of $10 million; generates $37 million of cash flow from operating activities over last nine monthsReports quarter-end cash balance of $38 million, up 2.7x versus prior yearSigns three ISG GovernX®client engagements worth a combined $6 millionSets fourth-quarter 2020 guidance: revenues of between $56 million and $58 million and adjusted EBITDA of between $7 million and $8 millionSTAMFORD, Conn., Nov. 09, 2020 (GLOBE NEWSWIRE) — Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, reported sequential revenue growth and...

Continue reading

Atomera to Participate in 11th Annual Craig-Hallum Alpha Select Conference

LOS GATOS, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today announced it will participate in the 11th Annual Craig-Hallum Alpha Select Conference to be held virtually on Tuesday, Nov 17, 2020.Atomera management will host one-on-one meetings with investors who are registered to attend the conference. For more information about the conference or to schedule a virtual one-on-one meeting with management, please contact your Craig-Hallum representative. Alternatively, please contact Atomera’s investor relations at investor@atomera.com.About AtomeraAtomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency...

Continue reading

InspireMD Announces Third Quarter 2020 Financial Results

Third quarter 2020 revenue returns to pre-COVID-19 levelsManagement to host investor conference call today, November 9, 2020 at 8:30 a.m. ETTEL AVIV, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR)(“Inspire” or the “Company”), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results for the third quarter ended September 30, 2020.Third Quarter 2020 and recent highlights:The U.S. Food and Drug Administration (FDA) granted InspireMD approval of its Investigational Device Exemption (IDE) application to initiate a pivotal study of CGuard™ EPS.  The company has begun to plan its pivotal study and has retained Dr. Christine Brennan, recognized expert in carotid artery disease,...

Continue reading

K92 Mining Announces Initial Phase 1 High-Grade Judd Vein System Drilling Results, Including 7.25m at 258.01 g/t AuEq

Results reported for the first four holes of K92’s Phase 1 underground drill program of the sparsely drill tested Judd vein system. Drilling has identified a well–mineralized vein system, intersecting multiple parallel veins trending North-South, ~150-200 m East and subparallel to the producing Kora deposit, near mine infrastructure and within the mining lease.JDD0006 intersected multiple veins, including recording 7.25 m at 256.09 g/t Au, 113 g/t Ag and 0.42 % Cu (258.01 g/t AuEq) on Judd Vein 1 (“J1”), approximately 30 m to the South and 50 m above the Judd bulk sample drive. This intersection is one of the highest-grade holes drilled by K92 at the Kainantu Gold Mine.JDD0003 intersected multiple vein intersections, including 4.52 m at 10.81 g/t Au, 53 g/t Ag and 7.35% Cu (22.40 g/t AuEq) at the J1 vein, approximately 60m above...

Continue reading

Clear Blue Technologies’ Off-Grid Lighting Illuminates Rural Intersections in North Dakota

TORONTO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (“Clear Blue”) (TSXV: CBLU), the Smart Off-Grid™ company, has completed four additional phases to bring the total to 7 phases of regional installations of its Illumient cleantech Smart Off-Grid lighting at rural intersections in North Dakota for the Department of Transport (DOT). As part of an initiative to reduce traffic accidents in the state, Clear Blue expects to have all lighting systems up and running by the end of 2020, illuminating over 100 rural intersections.In 2018, North Dakota’s DOT issued the Vision Zero Plan, focused on reducing motor vehicle crash fatalities on state and local roadways by 2025. A vital component in reducing traffic accidents was bringing lighting solutions to rural intersections across the state, however, these rural...

Continue reading

Rugby Mining Limited Announces Initial Drilling Results Provided by Calidus Resources Limited on the Otways Project, Australia

VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Rugby Mining Limited (“Rugby” or the “Company”) (TSX-V: RUG) is pleased to report that joint-venture partner Calidus Resources Limited (ASX:CAI, “Calidus”) have reported partial results from their first reconnaissance drilling program on Rugby’s Otways Project, Pilbara Australia. Calidus recently entered into a Heads of Agreement with the Company to earn up to 70% interest as reported in news release NR2004.Calidus recently completed five RC holes and one diamond hole with assays returning broad zones of copper mineralization. The results confirm historic intercepts.Highlights include:43 meters (“m”) @ 0.70% Cu (incl 10m @ 1.64%) from 0-43m in hole 20OTRC00218m @ 0.33% Cu from 18-36m in hole 20OTRC00313m @ 0.35% Cu from 60-73m in hole 20OTRC00353m @ 0.17% Cu from 0-53m...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.